V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004652 | 290003406 | 1.75 | 57 | Curative (C) | 2016-11-18 | 2016-11-24 | Carboplatin + Etoposide iv&po | N | N | 290021555 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004653 | 290003406 | null | 100 | Neo-adjuvant (N) | 2015-07-03 | 2015-07-27 | Capecitabine (21days) + Carboplatin | N | N | 290021555 | CARBOPLATIN + CETUXIMAB + FU |
| 290004654 | 290003407 | null | 96 | Curative (C) | 2015-06-26 | 2015-06-26 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 290021558 | FLUOROURACIL |
| 290004655 | 290003408 | 1.71 | 54.3 | Curative (C) | 2015-07-04 | 2015-07-24 | Carboplatin+Fluorouracil 4 or 5 day | N | Y | 290021559 | CAPECITABINE + RT |
| 290004656 | 290003409 | 1.81 | 35.8 | Adjuvant (A) | 2016-04-26 | 2016-05-23 | FCarboSt | 2 | null | 290021561 | CAPECITABINE + RT |
| 290004657 | 290003410 | null | 66.7 | Palliative (P) | 2017-07-20 | 2017-08-12 | Gemcitabine weekly | N | N | 290021562 | GEMCITABINE |
| 290004658 | 290003411 | 1.74 | 59.1 | Palliative (P) | null | 2016-02-21 | CVD (skin) | N | N | 290021563 | IRINOTECAN + MDG |
| 290004659 | 290003412 | null | null | Curative (C) | 2000-10-31 | 2015-04-12 | Capecitabine | N | null | 290021565 | CARBOPLATIN + PACLITAXEL |
| 290004660 | 290003413 | 1.72 | null | Palliative (P) | 2016-05-19 | 2016-06-06 | CETUXIMAB + RT | N | N | 290021567 | CAPECITABINE + RT |
| 290004661 | 290003414 | 1.79 | 76 | Palliative (P) | 2016-10-25 | 2016-10-30 | OCTREOTIDE | 02 | N | 290021568 | MCX |
| 290004662 | 290003415 | 1.6 | null | Adjuvant (A) | 2013-04-27 | 2013-05-10 | Cetuximab 7 day (>Cycle 2) | N | N | 290021569 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004663 | 290006527 | 1.7 | 56 | Curative (C) | 2014-08-25 | 2014-09-07 | Carboplatin AUC 6 - 10 | 02 | null | 290021571 | FLUOROURACIL |
| 290004664 | 290003416 | null | null | Palliative (P) | 2015-04-11 | 2015-05-16 | CISPLATIN + FLUOROURACIL | Y | N | 290021572 | CARBOPLATIN |
| 290004665 | 290003416 | 1.68 | 55 | Palliative (P) | 2017-02-23 | 2017-03-08 | PLATO Trials | 01 | N | 290021572 | CARBOPLATIN + RT |
| 290004666 | 290003417 | 1.57 | 68.6 | Disease modification (D) | 2018-10-20 | 2018-10-26 | Cisplatin + Vinorelbine (IV) | 02 | N | 290021576 | CARBO + FLUOROURACIL |
| 290004667 | 290003418 | 1.51 | 57.7 | Palliative (P) | 2015-12-12 | 2016-01-10 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | Y | 290021579 | CARBO + FLUOROURACIL |
| 290004668 | 290003419 | 1.78 | null | null | 2017-03-08 | 2017-03-21 | Everolimus 10mg | 2 | Y | 290021580 | ECX |
| 290004669 | 290003420 | 1.85 | null | Not known (9) | 2015-01-05 | 2015-01-05 | Capecitabine + Streptozocin | N | null | 290021581 | CHLORAMBUCIL + RITUXIMAB |
| 290004670 | 290003421 | 1.83 | 65.9 | Curative (C) | 2017-01-15 | 2017-02-02 | Oxaliplatin + Raltitrexed | N | Y | 290021584 | CAPECITABINE + CISPLATIN |
| 290004671 | 290003422 | 0 | 81.2 | null | 2017-12-24 | 2017-12-25 | CETUXIMAB + RT | 2 | N | 290021587 | CARBOPLATIN + ETOPOSIDE |
| 290004672 | 290003423 | 1.49 | 42.1 | Palliative (P) | 2013-05-09 | 2013-05-09 | GEMCITABINE | 2 | N | 290021588 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004673 | 290003424 | 1.68 | null | Palliative (P) | 2014-09-10 | 2015-06-25 | CARBOPLATIN + RT | N | N | 290021589 | LANREOTIDE |
| 290004674 | 290003425 | 1.77 | 60 | Palliative (P) | 2016-09-03 | 2016-09-03 | Bevacizumab + Oxaliplatin +MdG | N | N | 290021591 | CISPLATIN + FLUOROURACIL |
| 290004675 | 290003426 | 1.71 | 54.7 | Palliative (P) | 2014-09-25 | 2014-10-08 | CISPLATIN + FLUOROURACIL | 2 | N | 290021592 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004676 | 290003427 | 1.65 | 66 | Curative (C) | 2014-08-18 | 2014-08-21 | Capecitabine | N | N | 290021593 | CISPLATIN + FLUOROURACIL |
| 290004677 | 290003428 | null | 48.5 | Not known (9) | null | 2016-07-29 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | N | 290021594 | CAPECITABINE + RT |
| 290004678 | 290003429 | 1.68 | 62.8 | Adjuvant (A) | 2015-04-19 | 2015-04-22 | CAPECITABINE + RT | 02 | null | 290021596 | IPILIMUMAB + NIVOLUMAB |
| 290004679 | 290003430 | null | 62.7 | Palliative (P) | 2016-08-29 | 2016-09-24 | Irinotecan + Modified De Gramont | N | N | 290021598 | CISPLATIN + FLUOROURACIL |
| 290004680 | 290003431 | 1.56 | 56.9 | Curative (C) | 2017-10-16 | 2017-11-01 | LANREOTIDE | N | N | 290021599 | MCX |
| 290004681 | 290003432 | 1.86 | 78.4 | null | 2013-05-29 | 2013-05-29 | Carboplatin + Etoposide iv&po | null | N | 290021601 | Y-90 |
| 290004682 | 290003433 | 1.78 | 86.5 | Disease modification (D) | 2015-03-06 | 2015-03-06 | CISPLATIN + FLUOROURACIL | N | N | 290021603 | CAPECITABINE + CARBOPLATIN |
| 290004683 | 290003434 | 1.5 | 88.2 | Palliative (P) | 2016-06-04 | 2016-06-04 | CISPLATIN + FLUOROURACIL + MITOMYCIN | 02 | N | 290021610 | GEMCITABINE |
| 290004684 | 290006529 | 1.7 | 73 | Palliative (P) | 2015-11-05 | 2016-08-19 | Cisplatin + Etoposide po&iv 3 day | 02 | N | 290021611 | GEMCITABINE |
| 290004685 | 290003435 | 1.79 | 88 | Curative (C) | 2015-11-28 | 2015-11-29 | CARBOPLATIN + RT | 2 | N | 290021612 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004686 | 290003435 | 1.57 | null | null | 2015-09-27 | 2015-10-18 | Gemcitabine weekly | N | N | 290021612 | CARBOPLATIN + RT |
| 290004687 | 290003435 | 1.75 | null | Palliative (P) | null | 2014-07-20 | Gemcitabine weekly | N | N | 290021612 | CAPECITABINE |
| 290004688 | 290003436 | 1.59 | 60.2 | Palliative (P) | 2014-06-20 | 2014-06-23 | Capecitabine | 02 | N | 290021621 | LANREOTIDE |
| 290004689 | 290003437 | 0 | 58.5 | Adjuvant (A) | 2017-06-10 | 2017-06-21 | Carboplatin AUC 2 - 5 | N | Y | 290021622 | LANREOTIDE |
| 290004690 | 290003438 | 1.68 | 97.2 | null | 2017-10-07 | 2017-10-07 | CARBOPLATIN | 2 | N | 290021623 | CAPECITABINE |
| 290004691 | 290003439 | 1.71 | 66.2 | Neo-adjuvant (N) | 2017-08-19 | 2017-09-01 | GEMCITABINE | 2 | N | 290021624 | CETUXIMAB |
| 290004692 | 290003440 | 1.55 | 0 | Palliative (P) | 2017-08-14 | 2017-09-12 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290021625 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004693 | 290003441 | 1.56 | null | Palliative (P) | 2015-12-18 | 2015-12-31 | OCTREOTIDE | N | N | 290021628 | CARBOPLATIN + ETOPOSIDE |
| 290004694 | 290003442 | 1.81 | 96 | Adjuvant (A) | 2015-09-29 | 2015-10-20 | Gemcitabine + Capecitabine | N | Y | 290021629 | LU-177 |
| 290004695 | 290003443 | null | 44.1 | Palliative (P) | 2015-08-23 | 2015-09-06 | CISPLATIN + FLUOROURACIL | N | N | 290021631 | CAPECITABINE |
| 290004696 | 290003444 | 1.62 | 63 | Palliative (P) | 2017-01-24 | 2017-02-01 | Fluorouracil + Folinic Acid Weekly | N | Y | 290021632 | CISPLATIN + FLUOROURACIL |
| 290004697 | 290003444 | 1.51 | 60.6 | Disease modification (D) | 2017-12-12 | 2018-01-07 | Carboplatin + Etoposide iv&po | N | N | 290021632 | PLATO TRIAL |
| 290004698 | 290003444 | 1.59 | 61.5 | Palliative (P) | 2017-05-03 | 2017-05-03 | Capecitabine 42days + RT | null | null | 290021632 | CAPECITABINE |
| 290004699 | 290003445 | 1.63 | 60.5 | Palliative (P) | 2014-08-06 | 2014-08-13 | Carboplatin + Vinorelbine Oral | 02 | N | 290021637 | CISPLATIN + ETOPOSIDE |
| 290004700 | 290003446 | 1.68 | null | Palliative (P) | 2016-04-15 | 2016-05-03 | Capecitabine + Cisplatin | N | N | 290021638 | OCTREOTIDE |
| 290004701 | 290003447 | 1.73 | 60.4 | Palliative (P) | 2017-04-10 | 2017-04-10 | GemCarbo Days 1+8 | null | N | 290021639 | FLUOROURACIL |